Aerie Pharmaceuticals last day of trading expected Nov. 18 as part of Alcon merger
Nov. 15, 2022 4:21 PM ETAerie Pharmaceuticals, Inc. (AERI)ALCBy: Jonathan Block, SA News Editor
- Aerie Pharmaceuticals' (NASDAQ:AERI) likely last day of trading on the Nasdaq will be on Nov. 18 as part of its merger with Alcon (ALC).
- With the acquisition, Alcon (ALC) gains Rocklatan and Rhopressa, eye drops to reduce intraocular pressure, as well as a pipeline of several clinical and preclinical candidates.
- In August, Alcon (ALC) said it would acquire Aerie (AERI) for ~$770M.